Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.

导出 LinkOut

翻译打印收藏纠错

作者： Michael D,Chuong ^[1] ; Mary Ann,Clark ^[2] ; Lauren E,Henke ^[3] ; Amar U,Kishan ^[4] ; Lorraine,Portelance ^[5] ; Parag J,Parikh ^[6] ; Michael F,Bassetti ^[7] ; Himanshu,Nagar ^[8] ; Stephen A,Rosenberg ^[9] ; Minesh P,Mehta ^[1] ; Tamer,Refaat ^[10] ; Justin M,Rineer ^[11] ; Adam,Smith ^[12] ; Steven,Seung ^[13] ; Bassem I,Zaki ^[14] ; Martin,Fuss ^[2] ; Raymond H,Mak ^[15]

作者单位： Miami Cancer Institute, Miami, FL, United States. ^[1] ViewRay, Inc., Denver, CO, United States. ^[2] Washington University, School of Medicine, St. Louis, MO, United States. ^[3] University of California, Los Angeles Medical Center, Los Angeles, CA, United States. ^[4] University of Miami, Miami, FL, United States. ^[5] Henry Ford Health System, Grosse Pointe Farms, MI, United States. ^[6] University of Wisconsin, Madison, WI, United States. ^[7] Weill Cornell Medicine, New York, NY, United States. ^[8] H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States. ^[9] Loyola University Chicago, Stritch School of Medicine, Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Maywood, IL, United States. ^[10] Orlando Health, Orlando, FL, United States. ^[11] McGlinn Cancer Institute at Reading Hospital, Tower Health, Reading, PA, United States. ^[12] Providence Cancer Institute, Portland, OR, United States. ^[13] Dartmouth-Hitchcock Norris Cotton Cancer Center, Lebanon, NH, United States. ^[14] Dana Farber/Brigham and Women's Cancer Center, Boston, MA, United States. ^[15]

关键词 APBI, accelerated partial breast irradiation ART ART, adaptive radiotherapy BED, biologically equivalent dose CAGR, compound annual growth rate CBCT, cone beam computerized tomography Care patterns GDPR, General Data Protection Regulation Gy, gray H&N, head and neck HIPAA, Health Insurance Portability and Accountability Act IGRT, image-guided radiation therapy MR, magnetic resonance MR-IGRT MRI, magnetic resonance imaging MRI-guided radiotherapy MRIdian, 0.35Tesla(T)-MRgRT MRgRT, magnetic resonance-guided radiotherapy MVCT, mega-voltage CT NSCLC, non-small cell lung cancer OAR, organs at risk On-table adaptive radiation therapy PHI, protected health information PTV, planning target volume RT, radiation therapy SABR, stereotactic ablative radiation therapy SBRT SBRT, stereotactic body radiotherapy Stereotactic body radiotherapy T, Tesla UHfx, ultra-hypofractionated linac, linear accelerator oART oART, on-table adaptive radiation therapy

DOI 10.1016/j.ctro.2022.11.013

PMID 36466748

发布时间 2022-12-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Clinical and translational radiation oncology

2023年38卷

161-168页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.

Clinical and translational radiation oncology

相似文献

Clinical and translational radiation oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.

Clinical and translational radiation oncology

相似文献

Clinical and translational radiation oncology

相关期刊

检索历史清除